Indeed, Competition will arrive... right now aurora can use them as a distribution tool... which is great for both parties, and a t/o will no doubt be imminent. But given this distribution scenario, I doubt cann have any urgency to develop their own stock... just a thought.. either way they will be ok. And I dare say long gone or taken out by the time big competition arrives in any case.
- Forums
- ASX - By Stock
- CAN
- Bottom
Bottom, page-14
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $13.55M |
Open | High | Low | Value | Volume |
3.1¢ | 3.1¢ | 3.1¢ | $12.09K | 390K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1079784 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 95458 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1079784 | 0.030 |
7 | 227000 | 0.029 |
2 | 719642 | 0.028 |
5 | 205555 | 0.027 |
3 | 165260 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 95458 | 1 |
0.032 | 134706 | 7 |
0.033 | 644176 | 6 |
0.034 | 83720 | 2 |
0.035 | 96457 | 5 |
Last trade - 10.31am 16/07/2024 (20 minute delay) ? |
Featured News
CAN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online